End-Stage Renal Disease (ESRD) Treatment Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

End-Stage Renal Disease (ESRD) Treatment Market is segmented By Treatment Modality (Hemodialysis, Peritoneal Dialysis, Kidney Transplantation), By Product Type (Dialysis Services, Dialysis Equipment, Medications), By End User (Hospitals, Dialysis Centers, Home Care Settings), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.

End-Stage Renal Disease (ESRD) Treatment Market is segmented By Treatment Modality (Hemodialysis, Peritoneal Dialysis, Kidney Transplantation), By Pro....

End-Stage Renal Disease (ESRD) Treatment Market Size

Market Size in USD

CAGR5.2%

Study Period	2024 - 2031
Base Year of Estimation	2023
CAGR	5.2%
Market Concentration	High
Major Players	Fresenius Medical Care, DaVita Inc., Baxter International Inc., Nipro Corporation, B. Braun Melsungen AG

*Disclaimer: Major players are listed in no particular order.

*Source: Coherent Market Insights

Want to purchase customized report?
please let us know !

End-Stage Renal Disease (ESRD) Treatment Market Analysis

The end-stage renal disease (ESRD) treatment market is estimated to be valued at USD 84.7 Bn in 2024 and is expected to reach USD 120.9 Bn by 2031, growing at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031. The aging population and growing prevalence of chronic kidney diseases around the world is expected to propel the demand for ESRD treatment in the forecast period.

End-Stage Renal Disease (ESRD) Treatment Market Report Snapshots

Buy Now